Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan

Bone Marrow Transplantation

Volumn 24, Issue 8, 1999, Pages 935-938

  Kinugawa, N ^a   Imashuku, S ^b   Hirota, Y ^b   Yamada, K ^b   Yamamoto, A ^b   Akazai, A ^b   Oda, M ^b   Miura, N ^b   Kakuta, H ^b   Sato, T ^b   Endo, M ^b   Takano, T ^b  

^a CHIBA CHILDREN'S HOSPITAL   (Japan)

^b NONE

Author keywords

Hematopoietic stem cell transplantation; Langerhans cell histiocytosis

Indexed keywords

ARTICLE; CASE REPORT; CHILD; FEMALE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTIOCYTOSIS; HUMAN; INFANT; JAPAN; LANGERHANS CELL; MALE; MORTALITY; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0032728905     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702001     Document Type: Article

References (15)

1. Gadner H, Heitger A, Grois N et al. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994; 23: 72-80.
2. Egeler RM, de Kraker J, Voute PA et al. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol 1993; 21: 265-270.
3. Ceci A, Terlizzi MD, Colella R et al. Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-HX83 study. Med Pediatr Oncol 1993; 21: 259-264.
4. Broadbent V, Gadner H. Current therapy for Langerhans cell histiocytosis. Hematol/Oncol Clin N Am 1998; 12: 327-338.
5. Kinugawa N, Miyazaki S, Ishii E et al. Second national survey of childhood Langerhans cell histiocytosis in Japan. Jpn J Pediatr Oncol 1998; 35: 18-22 (in Japanese).
6. Imashuku S, Hibi S, Miyazaki S et al. LCH Study Group protocol for patients with multi-system, multi-site lesions. Jpn J Pediatr Oncol 1997; 34: 206-209 (in Japanese).
7. Ringden O, Ahstrom L, Lonnqvist B et al. Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis-X. New Engl J Med 1987; 316: 733-735.
8. Stoll M, Freund M, Schmid H et al. Allogeneic bone marrow transplantation for Langerhans cell histiocytosis. Cancer 1990; 66: 284-288.
9. Greinix HT, Storb R, Sanders JE, Petersen FB. Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis. Bone Marrow Transplant 1992; 10: 39-44.
10. Frost JD, Wiersma SR. Progressive Langerhans cell histiocytosis in an infant with Klinefelter syndrome successfully treated with allogeneic bone marrow transplantation. J Ped Hematol/Oncol 1996; 18: 396-400.
11. Conter V, Reciputo A, Arrigo C et al. Bone marrow transplantation for refractory Langerhans cell histiocytosis. Hematologica 1996; 81: 5468-5471.
12. Ayas M, Mustafa M, Al-Mahr M et al. Bone marrow transplantation as a salvage therapy for refractory disseminated Langerhans Histiocytosis. Proceeding of 14th Annual meeting of the Histiocyte Society in Kyoto, 1998 (Abstr. p36).
13. Egeler RM, Anderson RA, Wolff JEA et al. Allogeneic peripheral blood stem cell transplantation in Langerhans cell histiocytosis. Proceeding of 14th Annual meeting of the Histiocyte Society in Kyoto, 1998 (Abstr. p34).
14. Murphy G, Bhan A, Sato S et al. A new immunological marker of Langerhans cells. New Engl J Med 1981; 304: 791-792.
15. Willman CL, Busque L, Griffith BB et al. Langerhans-cell histiocytosis (histiocytosis X) - a clonal proliferative disease. New Engl J Med 1994; 331: 154-160.